Following recent analysis in the target tissue of RA [43], future longitudinal studies of TNF inhibition at the functional level are needed to corroborate whether responder patients are enriched in macrophage and B cell subtypes that are sensitive to TNF and, therefore, susceptible to be targeted by TNF blocking. Here, TNF is linked to rheumatoid arthritis.